165 related articles for article (PubMed ID: 7539881)
1. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.
Haratake J; Hashimoto H
Liver; 1995 Feb; 15(1):9-15. PubMed ID: 7539881
[TBL] [Abstract][Full Text] [Related]
2. [An immunohistochemical study on primary carcinoma of the liver].
Seo JK
J UOEH; 1989 Dec; 11(4):429-39. PubMed ID: 2481871
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of sarcomatoid liver carcinomas.
Haratake J; Horie A
Cancer; 1991 Jul; 68(1):93-7. PubMed ID: 1710948
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
6. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Ma CK; Zarbo RJ; Frierson HF; Lee MW
Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
Herrmann G
Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB
Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382
[TBL] [Abstract][Full Text] [Related]
10. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
[TBL] [Abstract][Full Text] [Related]
12. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
[TBL] [Abstract][Full Text] [Related]
13. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.
Kano Y; Kakinuma S; Goto F; Azuma S; Nishimura-Sakurai Y; Itsui Y; Nakagawa M; Kudo A; Tanabe M; Kirimura S; Amano T; Ito T; Akashi T; Asahina Y; Watanabe M
Clin J Gastroenterol; 2014 Oct; 7(5):449-54. PubMed ID: 26184027
[TBL] [Abstract][Full Text] [Related]
14. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
Xu J; Zhang C; Qiao A; Xi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
Imai Y; Oda H; Arai M; Shimizu S; Nakatsuru Y; Inoue T; Ishikawa T
Jpn J Cancer Res; 1996 Oct; 87(10):1056-62. PubMed ID: 8957064
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study on cholangiolocellular carcinoma.
Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
19. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
Martín de las Mulas J; Gómez-Villamandos JC; Pérez J; Mozos E; Estrado M; Méndez A
Res Vet Sci; 1995 Sep; 59(2):124-7. PubMed ID: 8525100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
